-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lumos Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
- Lumos Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $173K, a 72.6% decline year-over-year.
- Lumos Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.41M, a 45.2% decline year-over-year.
- Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $2.55M, a 164% increase from 2022.
- Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $965K, a 243% increase from 2021.
- Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $281K, a 95.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)